SCHEMBL8773544

SCHEMBL8773544

Cc1ccc2c(c1)C(=O)C(=O)CO2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.49
CYP19A1 P11511 1/20 0.45
KDM4E B2RXH2 5/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
ATM Q13315 2/20 0.43
HTT P42858 2/20 0.43
MAOB P27338 2/20 0.42
MAOA P21397 1/20 0.42
MAPT P10636 4/20 0.42
RAB9A P51151 3/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
ALOX12 P18054 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL95448 0.89 MMP12 (0.51) MMP12CYP19A1KDM4EKMT2AMEN1
SCHEMBL28432086 0.84 MMP12 (0.47) MMP12CYP19A1KDM4EKMT2AMEN1
SCHEMBL10977113 0.82 METAP1 (0.53) MMP12CYP19A1KDM4EKMT2AMEN1
SCHEMBL2760390 0.82 ALDH1A1 (0.54) MMP12CYP19A1KDM4EKMT2AMEN1
SCHEMBL28426296 0.81 CYP19A1 (0.49) MMP12CYP19A1KDM4EKMT2AMEN1
SCHEMBL8798148 0.80 ALDH1A1 (0.68) KDM4EKMT2AMAPTRAB9AALDH1A1
SCHEMBL10962514 0.79 MMP12 (0.46) MMP12CYP19A1KDM4EKMT2AMEN1
SCHEMBL3200283 0.77 APP (0.48) MMP12CYP19A1KDM4EKMT2AMEN1
SCHEMBL3200278 0.77 APP (0.48) MMP12CYP19A1KDM4EKMT2AMEN1
SCHEMBL2056164 0.77 MAOB (0.54) MMP12CYP19A1KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778970-B2 Benzyl piperidine compound DAINIPPON SUMITOMO PHARMA CO., LTD (JP) 2014-07-15 US disclosed
US-8778970-B2 Benzyl piperidine compound DAINIPPON SUMITOMO PHARMA CO., LTD (JP) 2014-07-15 US disclosed
EP-2463286-A1 BENZYL PIPERIDINE COMPOUND Dainippon Sumitomo Pharma Co., Ltd. (JP) 2012-06-13 EP disclosed
US-20120130077-A1 BENZYL PIPERIDINE COMPOUND DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-05-24 US disclosed
US-20120130077-A1 BENZYL PIPERIDINE COMPOUND DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-05-24 US disclosed
WO-2011016468-A1 BENZYL PIPERIDINE COMPOUND 大日本住友製薬株式会社 (JP) 2011-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120130077-A1 BENZYL PIPERIDINE COMPOUND HTR1D, HTR1A, HTR1B MMP12 4472/4885CYP19A1 1351/4885KDM4E 807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.